Concepedia
1
Publications
82
Citations
H-Index
2018
Active since
Affiliations
Dynavax Technologies (United States)(Current)
Émilie Degagné is an author at Dynavax Technologies (United States).
Publications per year
2018–2018
Inhaled TLR9 Agonist Renders Lung Tumors Permissive to PD-1 Blockade by Promoting Optimal CD4+ and CD8+ T-cell Interplay
Marilena Gallotta, Hikmat Assi, Émilie Degagné et al. · Cancer Research · 2018 · 82 citations · Full text
Rows per page
1–1 of 1